Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Mode

  2.3.2 Market Size By Application

  2.3.3 Market Size By Method

 2.3.4 Market Size By End Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Nucleic Acid Materials, Lipids, Polymers & Reagent Suppliers

3.4.2 Non-Viral Gene Delivery Technology & Transfection Platform Developers

3.4.3 CDMOs, Research Tool Providers & Bioprocess Distribution Networks

3.4.4 Gene Therapy Research Ecosystem, Biotechnology Companies & Academic Institutes

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Gene Delivery Research & Market Demand Analysis

 4.1.1 Overview

 4.1.2 Non-Viral Gene Delivery Adoption Trends, 2022–2035

 4.1.3 Demand Analysis by Mode, Application, Method & End Use

4.2 Non-Viral Delivery Technology & Innovation Landscape

 4.2.1 Overview

 4.2.2 Lipid Nanoparticles, Polymer-Based Systems & Physical Delivery Technology Trends

 4.2.3 Genome Editing, mRNA Delivery & Cell Engineering Platform Analysis

4.3 Commercialization, Investment & Competitive Analysis

 4.3.1 Overview

 4.3.2 Biopharmaceutical Investment, CDMO Expansion & Research Funding Trends

 4.3.3 Strategic Collaborations, Product Launches & Regulatory Developments Analysis

4.4 Translational Research & Therapeutic Development Insights

 4.4.1 Overview

 4.4.2 Gene Therapy, Cell Therapy & Nucleic Acid Therapeutics Trends

 4.4.3 Clinical Translation, Manufacturing Scale-Up & Delivery Efficiency Analysis

 4.4.4 Precision Medicine, Personalized Therapeutics & Next-Generation Gene Delivery Trends

5. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast, By Mode, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Chemical

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Physical

6. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Research

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Therapeutics

7. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast, By Method, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Ex Vivo

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 In Vivo

 7.4 In Vitro

8. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Biotechnology and Biopharmaceutical Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Research and Academic Institutes

 8.4 Others

9. Non-Viral Gene Delivery Technologies Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2022–2035

 9.2.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2022–2035

 9.2.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2022–2035

 9.2.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2022–2035

 9.2.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2022–2035

 9.3.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2022–2035

 9.3.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2022–2035

 9.3.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2022–2035

 9.3.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2022–2035

 9.4.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2022–2035

 9.4.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2022–2035

 9.4.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2022–2035

 9.4.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2022–2035

 9.5.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2022–2035

 9.5.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2022–2035

 9.5.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2022–2035

 9.5.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Mode, 2022–2035

 9.6.3 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Application, 2022–2035

 9.6.4 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Method, 2022–2035

 9.6.5 Non-Viral Gene Delivery Technologies Market Size & Forecast, By End Use, 2022–2035

 9.6.6 Non-Viral Gene Delivery Technologies Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Mode/Service & Application Benchmarking

  10.4.1 Mode/Service Specifications & Features By Key Players

  10.4.2 Mode/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Polyplus-transfection SA

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Mode/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 Mirus Bio LLC

10.6.3 Altogen Biosystems

10.6.4 SignaGen Laboratories

10.6.5 OZ Biosciences

10.6.6 MaxCyte Inc.

10.6.7 IBA GmbH

10.6.8 Thermo Fisher Scientific

10.6.9 Merck KGaA

10.6.10 QIAGEN N.V.

10.6.11 Takara Bio Inc.

10.6.12 Biontex Laboratories GmbH

10.6.13 Promega Corporation

10.6.14 Bio-Rad Laboratories Inc.

10.6.15 GenScript Biotech Corporation

10.6.16 Lonza Group AG

10.6.17 Agilent Technologies Inc.

10.6.18 EMD Millipore

10.6.19 OriGene Technologies Inc.

10.6.20 Bio-Techne Corporation

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures